Edwards Lifesciences Corp. (EW)

194.33
NYSE : Health Technology
Prev Close 193.08
Day Low/High 193.13 / 195.24
52 Wk Low/High 134.53 / 197.86
Avg Volume 1.27M
Exchange NYSE
Shares Outstanding 208.50M
Market Cap 40.26B
EPS 3.50
P/E Ratio 53.63
Div & Yield N.A. (N.A)

The Next Deals Are in Hospital

A wave of M&A in the health sector makes sense.

Edwards Lifesciences upgraded at JMP

Gems Hiding in the Shadows

If you step out of the blinding spotlight, the truly rewarding buying opportunities become obvious.

Don't Lose Track of Your Trades

Don't Lose Track of Your Trades

Keep a tally that summarizes all your related holdings: stock, calls and puts.

Edwards Gains on Heart Valve Ruling

Sell into the pop as the good news is set.

Big Returns Will Bloom at Flowers Foods, Edwards Lifesciences

Big Returns Will Bloom at Flowers Foods, Edwards Lifesciences

Shares of heart valve maker Edwards Lifesciences are cheap and out of favor, making this a great opportunity to buy stock in a best of breed company.

Edwards Lifesciences upgraded at Wells

Buy the Bear, Pass on the Bull

Buy the Bear, Pass on the Bull

Analyzing a pair of picks by Zacks.

Catch Edwards Lifesciences While It's Low

Catch Edwards Lifesciences While It's Low

The company is a steady grower, but its stock has swooned.

Edwards Lifesciences downgraded at Wells

Edwards estimates increased at UBS

For Apple Heads

It guides to a very weak third quarter. Apple (AAPL) met earnings expectations but guides to a very weak third quarter. The gross margin projection for both the recently reported period and the third quarter of 2013 likely plays into the bears' conc...

Stocks Under $10: Chase This Winner?

Stocks Under $10: Chase This Winner?

Portfolio Mgr. David Peltier analyzes one of the early low-dollar winners of 2013.

Stocks Under $10: At an Inflection Point

Stocks Under $10: At an Inflection Point

Portfolio Mgr. David Peltier analyzes a low-dollar stock on the verge of a potential turnaround.

Gilead, Edwards Offer Healthy 2013 Returns

Gilead, Edwards Offer Healthy 2013 Returns

Dr. Mark Bussard, Healthcare Analyst at T Rowe Price, names his favorite healthcare stocks for 2013 including Gilead and Edwards Lifesciences.

Edwards Lifesciences downgraded at UBS

Off the Charts

Off the Charts

Volume remains light and leadership is scarce, two things that traders do not like to see.